Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Genome-wide high-content siRNA screens for regulators of Parkin translocation in selective mitophagy (Dharmacon Library)
Assay data:826 Active, 18119 Tested
SummaryPubMed Citation
MDR-1
Assay data:353 Active, 779 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
High-throughput multiplex screening for ABC transporter inhibitors: specifically ABCB1 screen, ABCG2 counter-screen
Assay data:130 Active, 193717 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by DepositorRelated BioAssays by Same ProjectRelated BioAssays by Target
Single point confirmation for ABC transporter inhibitors: specifically ABCB1 screen, ABCG2 counter-screen
Assay data:18 Active, 273 Tested
Dose Response for ABC transporter inhibitors: specifically ABCB1 screen, ABCG2 counter-screen
Assay data:9 Active, 5 Activity ≤ 1 µM, 40 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Same ProjectRelated BioAssays by Target
Summary of High-throughput multiplex screening for ABC transporter inhibitors
Assay data:1 Active, 1 Tested
siRNA Circadian Assay
Assay data:527 Active, 33364 Tested
SummaryPubMed CitationRelated BioAssays by Depositor
Chemo Reversal assay in ABCB1-expressing cells for one set of SAR compounds
Assay data:1 Active, 15 Tested
SAR hit validation chemo-reversal assay specifically in in ABCB1-expressing cells, ABCG2 counterscreen
Assay data:9 Active, 37 Tested
Dose Response for ABC transporter inhibitors: specifically ABCB1 screen, ABCG2 counter-screen. Follow-up assay.
Assay data:36 Active, 89 Tested
Chemo Reversal assay in ABCB1-expressing cells for set2 of SAR compounds
Assay data:3 Active, 10 Tested
Dose Response for ABC transporter inhibitors: specifically ABCG2 screen, ABCB1 counter-screen. Follow-up assay on set 2
Assay data:63 Active, 16 Activity ≤ 1 µM, 67 Tested
Dose Response for ABC transporter inhibitors: specifically ABCB1 screen, ABCG2 counter-screen. Follow-up assay for Set 2
Assay data:59 Active, 6 Activity ≤ 1 µM, 67 Tested
An siRNA screen for human genes that are involved in human papilloma virus (HPV) E2 transcriptional repression of the E6 and E7 oncogenes
Assay data:497 Active, 21019 Tested
qHTS for characterization and localization of zebrafish homologs of the human ABCB1 multidrug transporter: P-gp overexpressing MDR-19 cells
Assay data:31 Active, 11 Activity ≤ 1 µM, 82 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Target
Genome-wide high-content siRNA screens for regulators of Parkin translocation in selective mitophagy (Ambion Library)
Assay data:9227 Active, 64752 Tested
Druggable Genome siRNA Screen for Enhancers of Camptothecin in MDA-MB-231 Breast Cancer Cells
Assay data:167 Active, 26449 Tested
Summary
RNAi screen for vorinostat resistance genes - Primary Screen
Assay data:450 Active, 18118 Tested
A whole genome RNAi screen highlights components of the ER/Golgi as a prominent source of resistance to immunotoxin-mediated cytotoxicity
Assay data:555 Active, 64752 Tested
InfectX: Pathogen infection siRNA screens
Assay data:115372 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on